Status:
COMPLETED
Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring
Lead Sponsor:
University of Florida
Conditions:
Type 1 Diabetes Mellitus
Continuous Glucose Monitor
Eligibility:
All Genders
15-24 years
Phase:
NA
Brief Summary
The goal of this pilot study is to produce a high-quality, theory-driven, therapeutic, web-based intervention that provides extended training and peer support to adolescents and young adults with type...
Eligibility Criteria
Inclusion
- Ability to read and speak English
- Diagnosed with type 1 diabetes (T1D) for \> 3 months before consent is obtained
- Aged \>15 years and \<24 years at time of enrollment
- Must have access to a smartphone, tablet or laptop/desktop computer with high speed internet access and speaker
- Must be using/initiating a Dexcom CGM
Exclusion
- Cognitive or learning disability (e.g., inability to read) that would preclude their ability to comply with the study protocol
- Significant medical comorbidity in the adolescent or young adult that could, in the opinion of the PI, affect subject's capacity to follow study protocol
- Previous use of a CGM within the last 3 months
- Unwilling or unlikely to return to clinic for a follow-up HbA1c test
- Unwillingness to accept randomization
Key Trial Info
Start Date :
March 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03367351
Start Date
March 9 2018
End Date
November 1 2018
Last Update
December 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32603